ADHD Incidence Increased Among Adults From 2020 to 2023
By Lori Solomon HealthDay Reporter
THURSDAY, Jan. 23, 2025 -- There have been recent fluctuations in the incidence of attention-deficit/hyperactivity disorder (ADHD) among U.S. adolescents and adults, according to a study published online Jan. 13 in Psychiatric Research & Clinical Practice.
Margaret L. Paul, from Saint Louis University, and colleagues sought to understand the incidence of and recent trends in new ADHD diagnoses among adolescents and adults between 2016 and 2023. The analysis included patient charts from 144,103 adolescents and adult patients seen in a single health system.
The researchers found that for adults, there was a significant (−10.6 percent) downward trend in ADHD incidence from 2016 to 2020 but a significant (+15.2 percent) upward trend from 2020 to 2023. A significant (−26.1 percent) downward trend was observed for adolescents between 2016 and 2018, followed by a stable incidence rate from 2018 to 2023.
"Advancing our understanding of diagnostic trends in clinical practice promotes accurate diagnosis and improved management of ADHD," the authors write. "Study findings support future investigation in identifying potential modifiable risk factors, ensuring sufficient treatment resources, developing targeted interventions, and addressing diagnostic disparities."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
AAP Updates Guidelines for Pediatric Atopic Dermatitis Management
MONDAY, May 19, 2025 -- In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for the treatment of children...
MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer
MONDAY, May 19, 2025 -- Use of magnetic resonance imaging (MRI)-guided biopsy (MRGB) could increase the durability of active surveillance (AS) in men with prostate cancer...
Wearable Sensor Can Monitor Sleep Apnea Treatment Response
MONDAY, May 19, 2025 -- A wearable pulse oximeter and connected software platform (Apnimed) shows promise for monitoring obstructive sleep apnea (OSA) and other sleep-related...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.